Cite
HARVARD Citation
Seed, R. et al. (n.d.). 722 Inhibition of integrin avß8-Mediated TGF-ß activation with C6D4 provides improved potency and selectivity vs general TGF-ß inhibitors for cancer immunotherapy. Journal for immunotherapy of cancer. pp. A764-A765. [Online].